FDA product code DLX: Hemagglutination Inhibition, Barbiturate

DLX is the FDA product code for hemagglutination inhibition, barbiturate. It is a Class II device, regulated under 21 CFR 862.3150 and reviewed by the Clinical Toxicology panel. Devices under DLX reach the market by 510(k); FDA lists no cleared 510(k)s for it.

Classification

FieldValue
Device nameHemagglutination Inhibition, Barbiturate
Device classClass II
Regulation21 CFR 862.3150
Review panelTX — Clinical Toxicology
Medical specialtyClinical Toxicology
Premarket route510(k)
Third-party 510(k) review eligibleYes

Recalls for DLX devices

FDA recall records list no recalls for product code DLX.

Frequently asked questions

What is FDA product code DLX?

DLX is the FDA product code for hemagglutination inhibition, barbiturate. It is a Class II device, regulated under 21 CFR 862.3150 and reviewed by the Clinical Toxicology panel.

What device class is DLX?

Class II, regulation 21 CFR 862.3150. Typical premarket route: 510(k).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Clinical Toxicology product codes · FDA product code lookup · 510(k) database search · 510(k) review times